Found: 5
Select item for more details and to access through your institution.
Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32149-8
- By:
- Publication type:
- Article
Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.791764
- By:
- Publication type:
- Article
Determinants of health as predictors for differential antibody responses following SARS-CoV-2 primary and booster vaccination in an at-risk, longitudinal cohort.
- Published in:
- PLoS ONE, 2024, v. 19, n. 4, p. 1, doi. 10.1371/journal.pone.0292566
- By:
- Publication type:
- Article
Nanovaccines Displaying the Influenza Virus Hemagglutinin in an Inverted Orientation Elicit an Enhanced Stalk‐Directed Antibody Response.
- Published in:
- Advanced Healthcare Materials, 2023, v. 12, n. 13, p. 1, doi. 10.1002/adhm.202202729
- By:
- Publication type:
- Article
SARS-CoV-2 serosurvey across multiple waves of the COVID-19 pandemic in New York City between 2020–2023.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-50052-2
- By:
- Publication type:
- Article